三维适形放疗联合替吉奥或卡培他滨治疗局部复发直肠癌临床疗效观察.DOC

三维适形放疗联合替吉奥或卡培他滨治疗局部复发直肠癌临床疗效观察.DOC

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
三维适形放疗联合替吉奥或卡培他滨治疗局部复发直肠癌临床疗效观察

SOX方案与XELOX方案同步放疗治疗术后复发胃癌疗效观察 白桦,梅家转#,栗敏,肖鹏(450003郑州 郑州人民医院肿瘤内科 ) 【摘要】<1.25m2,40mg;1.25~1.5m250mg;>)】】】Efficacy of concurrent chemoradiotherapy of SOX Regimen and XELOX Regimen for postoperative recurrent gastric carcinoma Bai Hua, Mei Jiazhuan, Li min,Xiao peng.Department of oncology ,the Peoples Hospital of zhengzhou, zhengzhou 450003.P.R.China 【Abstract】OTo evaluate the efficacy and safety of concurrent chemoradiotherapy of SOX regimen and XELOX regimen for postoperative recurrent elderly gastric carcinoma.Methods: Sixty-six patients with postoperative recurrent elderly gastric cancers were randomly divided into two groups, 34 cases in the SOX group received S-1(<1.25m2,40mg;1.25~1.5m2,50mg;>1.5m2,60mg),twice/day, oral adminsirtation,d1~14; L-OHP (85mg/m2,d1);three-dimensional conformal 郑州市科技计划攻关基金资助项目 (083SGYS33238-1) 作者简介:白桦,女,主治医师,主要从事恶性肿瘤的综合治疗,zzrmyyzlk@126.com 通讯作者:梅家转,男,博士,主任医师,主要从事恶性肿瘤的综合治疗,E-mail:mjzhuan@163.comradiation (1.8Gy/d, 5d/w and the total doses was 45Gy) ;32 cases in the XELOX group were treated with capecitabine (2000mg/m2,separated to twice,d1~14),plus the same regimen of radiation and L-OHP, three weeks was a cycle.The efficacy and toxicity was evaluated after two cycles. Results: The efficacy and toxicity could be evaluated in the 66 cases., the overall response rates were 55.9% and 46.9%, the median TTP was 6.3 months,5.8 months, the median OS was 12.8 months,12.2 months, there were no significanct difference(P>0.05),the most common toxicities of the two groups were neutropenia, thrombopenia,nausea vomiting and diarrhea, which could be tolerated. However, the Hand-foot syndrome rate of the SOX group exceeded the XELOX group(P<0.05). C: The efficacy of the two groups is simple, but the concurrent chemoradiotherapy of SOX regimen for postoperative recurrent gastric carcinoma patients is better than concurrent chemoradiotherapy of XELOX regimen in well-tolerated toxicity,and worth to further study and popularize. [Keywrods]:gastr

文档评论(0)

fengruiling + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档